On November 29, the Department of Justice’s Antitrust Division submitted a statement in response to a request from Michigan State Senator Peter MacGregor’s (R) about the possible competitive effects of Senate Bill 753. The bill requires providers to get informed consent from patients, comply with “applicable standards of care,” and refer patients to local providers where indicated. The bill also does not impose a state licensure requirement and it allows authorized health professionals to prescribe drugs that are non-controlled substances through telehealth services.
DOJ encourages lawmakers to consider the competitive effects of legislation, while, recognizing the critical importance of patient health and safety, noting the consumer benefits that will be achieved by expanding new ways to access health care.
The bill is now in third reading, awaiting Michigan's House vote.